Information Provided By: 
Fly News Breaks for June 24, 2015
ESPR
Jun 24, 2015 | 07:01 EDT
Credit Suisse assumed coverage on Esperion with a Neutral rating from an Outperform rating and lowered its price target to $86 from $130. The analyst would like to see more visibility on the upcoming FDA decision and product labels for PCSK9s, output of End of Phase 2 FDA meeting with the FDA in August, and clarity on the mechanism of action for ETC-1002 before recommending shares.
News For ESPR From the Last 2 Days
There are no results for your query ESPR
